Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Int Health ; 14(Suppl 2): ii70-ii73, 2022 09 21.
Artigo em Inglês | MEDLINE | ID: mdl-36130247

RESUMO

Living in an increasingly interconnected world, epidemics and pandemics are increasingly likely to be a vista for the future. This, coupled with the likely devastating effects of climate change, means that humanitarian crises are likely to increase. Now, more than ever before, is the time to scale up investment in prevention and preparedness strategies, and to review our current approaches to delivering health services, including those that address neglected tropical diseases. The Ascend West and Central Africa programme has illustrated the importance of innovation, multisector partnerships, resilience and the opportunity for change.


Assuntos
Pandemias , Medicina Tropical , Humanos , Doenças Negligenciadas/epidemiologia , Doenças Negligenciadas/prevenção & controle , Pandemias/prevenção & controle
2.
Int Health ; 14(Suppl 1): i17-i23, 2022 04 06.
Artigo em Inglês | MEDLINE | ID: mdl-35169850

RESUMO

BACKGROUND: Onchocerciasis is targeted for elimination of transmission by 2030 in at least 21 countries. To achieve this, recent and accurate data on the extent and intensity of onchocerciasis transmission are required. This will include mapping areas previously unassessed, or remapping of areas that were last visited as part surveys aiming to prevent blindness, not assess transmission in totality. There is near universal acceptance of the need to carry out these mapping reassessments, to achieve equitable and lasting elimination of onchocerciasis transmission. However, there is no consensus on how to conduct onchocerciasis elimination mapping (OEM), and little published data to inform policymakers and programme managers, including on cost. METHODS: Here, we summarise the methods and cost implications of conducting pilot OEM surveys in Ghana and Nigeria in 2018. We have included a breakdown of costs incurred overall, per person and per implementation unit in each country, as well as detailed analysis of the cost categories and the main cost drivers. RESULTS: The procurement and logistics of diagnostics accounted for more than one-third of the total cost, a significant cost driver. CONCLUSIONS: This information will be valuable to policymakers and donors as they seek to prioritise onchocerciasis elimination and plan to complete OEM.


Assuntos
Oncocercose , Custos e Análise de Custo , Erradicação de Doenças/métodos , Estudos de Viabilidade , Humanos , Ivermectina/uso terapêutico , Oncocercose/prevenção & controle
3.
Trans R Soc Trop Med Hyg ; 115(5): 441-446, 2021 05 08.
Artigo em Inglês | MEDLINE | ID: mdl-33570149

RESUMO

The COVID-19 pandemic hit at a time when the Ascend West and Central Africa programme was nearing the end of its first year of a 3-y programme. This article reflects on key lessons learnt from the rapid adaptation of an integrated neglected tropical disease (NTD) programme to support COVID-19 responses in 11 countries. It shares the experiences of adopting a flexible and directive approach, leveraging the NTD network and relationships, and working in collaboration with multiple ministry departments, commercial sector partners and the UK Foreign Commonwealth Development Office to repurpose over £6 million of budget.


Assuntos
COVID-19/prevenção & controle , Participação da Comunidade , Prestação Integrada de Cuidados de Saúde , Pandemias/prevenção & controle , Medicina Tropical/métodos , Comunicação , Agentes Comunitários de Saúde , Humanos , Doenças Negligenciadas/prevenção & controle , Saúde Pública , Risco , SARS-CoV-2
5.
Trans R Soc Trop Med Hyg ; 113(12): 829-834, 2019 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-31111941

RESUMO

People with disabilities and the neglected tropical diseases (NTDs) are separately receiving increased focus. In light of this positive development, and the similarities and intersections between the negative impacts experienced by both people with disabilities and people with NTDs, we believe now is the right time to focus attention on the overlap between the two. Both people with NTDs and people with disabilities experience a myriad of overlapping negative health, financial and socio-cultural consequences. Despite this, we believe that disability is not yet properly prioritised on the development agenda, and that there are multiple opportunities to make NTD programming more inclusive, to the benefit of those at this neglected intersection and beyond. There are both opportunities and need to scale up, integrate, and invest in inclusive, health system-focused NTD programming. Realisation of the Sustainable Development Goals, Universal Health Coverage, and the control and elimination of NTDs all rely on ensuring people with disabilities are not left behind.


Assuntos
Controle de Doenças Transmissíveis/tendências , Pessoas com Deficiência , Saúde Global , Doenças Negligenciadas/prevenção & controle , Medicina Tropical/tendências , Congressos como Assunto , Humanos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA